Cargando…

Correction: Rapamycin Is Neuroprotective in a Rat Chronic Hypertensive Glaucoma Model

Detalles Bibliográficos
Autores principales:	Su, Wenru, Li, Zuohong, Jia, Yu, Zhuo, Yehong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398837/ https://www.ncbi.nlm.nih.gov/pubmed/30830938 http://dx.doi.org/10.1371/journal.pone.0213489

Ejemplares similares

Rapamycin Is Neuroprotective in a Rat Chronic Hypertensive Glaucoma Model
por: Su, Wenru, et al.
Publicado: (2014)

Corrigendum to ‘microRNA-21a-5p/PDCD4 axis regulates mesenchymal stem cell-induced neuroprotection in acute glaucoma’
por: Su, Wenru, et al.
Publicado: (2023)

Laquinimod Inhibits Inflammation-Induced Angiogenesis in the Cornea
por: Li, Zuohong, et al.
Publicado: (2020)

Clinical Outcomes of FP-7/8 Ahmed Glaucoma Valves in the Management of Refractory Glaucoma in the Mainland Chinese Population
por: Zhu, Yingting, et al.
Publicado: (2015)

Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin
por: Harder, Jeffrey M., et al.
Publicado: (2020)

Correction to: LncRNA H19 initiates microglial pyroptosis and neuronal death in retinal ischemia/reperfusion injury
por: Wan, Peixing, et al.
Publicado: (2022)

Autophagy in Retinal Ganglion Cells in a Rhesus Monkey Chronic Hypertensive Glaucoma Model
por: Deng, Shuifeng, et al.
Publicado: (2013)

CircXPO5 Plays a Neuroprotective Function in the Lateral Geniculate Nucleus of Glaucoma by Regulating GRIN2A
por: Yan, Zhichao, et al.
Publicado: (2022)

Correction: Systemically administered peptain-1 inhibits retinal ganglion cell death in animal models: implications for neuroprotection in glaucoma
por: Stankowska, Dorota L., et al.
Publicado: (2019)

Trimetazidine protects retinal ganglion cells from acute glaucoma via the Nrf2/Ho-1 pathway
por: Wan, Peixing, et al.
Publicado: (2017)

TET-dependent GDF7 hypomethylation impairs aqueous humor outflow and serves as a potential therapeutic target in glaucoma
por: Wan, Peixing, et al.
Publicado: (2021)

Correction: Beneficial Role of Rapamycin in Experimental Autoimmune Myositis
por: Prevel, Nicolas, et al.
Publicado: (2014)

Correction to: Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial
por: Leung, Christopher Kai Shun, et al.
Publicado: (2022)

Correction: Inhibition of Let7c MicroRNA Is Neuroprotective in a Rat Intracerebral Hemorrhage Model
Publicado: (2014)

Correction: Therapeutic effects of rapamycin and surgical decompression in a rabbit spinal cord injury model
por: Zhang, Xin, et al.
Publicado: (2020)

Correction: Retinal cholesterol metabolism is perturbated in response to experimental glaucoma in the rat
Publicado: (2023)

Correction to: Rapamycin-induced hyperglycemia is associated with exacerbated age-related osteoarthritis
por: Minton, Dennis M., et al.
Publicado: (2022)

Precise long non-coding RNA modulation in visual maintenance and impairment
por: Wan, Peixing, et al.
Publicado: (2017)

Necroptosis: A Novel Pathway in Neuroinflammation
por: Yu, Ziyu, et al.
Publicado: (2021)

Neuroprotective Effect of Statins in a Rat Model of Chronic Ocular Hypertension
por: Kim, Mi-Lyang, et al.
Publicado: (2021)

Correction to: Management of Hypertension in Chronic Kidney Disease
por: Pugh, Dan, et al.
Publicado: (2020)

Correction: A novel therapeutic approach to colorectal cancer in diabetes: role of metformin and rapamycin
por: Geagea, Alice Gerges, et al.
Publicado: (2019)

Correction: Brain targeted delivery of rapamycin using transferrin decorated nanostructured lipid carriers
por: Khonsari, Fatemeh, et al.
Publicado: (2022)

Correction to: Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension
por: Hoy, Sheridan M.
Publicado: (2018)

Neuroprotection in glaucoma
por: Vasudevan, Sushil K, et al.
Publicado: (2011)

Neuroprotection in Glaucoma
por: Nilforushan, Naveed
Publicado: (2012)

Neuroprotection in Glaucoma
por: Doozandeh, Azadeh, et al.
Publicado: (2016)

Neuroprotection in glaucoma
por: Vishwaraj, C R, et al.
Publicado: (2022)

Correction: Mice Fed Rapamycin Have an Increase in Lifespan Associated with Major Changes in the Liver Transcriptome
Publicado: (2014)

Correction for: Rapamycin doses sufficient to extend lifespan do not compromise muscle mitochondrial content or endurance
por: Ye, Lan, et al.
Publicado: (2020)

A Topical Formulation of Melatoninergic Compounds Exerts Strong Hypotensive and Neuroprotective Effects in a Rat Model of Hypertensive Glaucoma
por: Dal Monte, Massimo, et al.
Publicado: (2020)

Correction: Retinal vasculature in glaucoma: a review
Publicado: (2018)

Correction: Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease
por: Spilman, Patricia, et al.
Publicado: (2011)

Correction: Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease
por: Spilman, Patricia, et al.
Publicado: (2011)

Neuroprotective effects of rapamycin on spinal cord injury in rats by increasing autophagy and Akt signaling
por: Li, Xi-Gong, et al.
Publicado: (2019)

Correction to “Molecular and Physiological Factors of Neuroprotection in Hypoxia-tolerant Models: Pharmacological Clues for the Treatment of Stroke”
por: Nathaniel, Thomas I, et al.
Publicado: (2015)

Correction to: “Carbamylated Erythropoietin: A Prospective Drug Candidate for Neuroprotection”
por: Chen, Jianmin, et al.
Publicado: (2016)

Correction to: Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study
por: Oddone, Francesco, et al.
Publicado: (2020)

Correction: Rapamycin Inhibits IGF-1-Mediated Up-Regulation of MDM2 and Sensitizes Cancer Cells to Chemotherapy
por: Du, Wei, et al.
Publicado: (2013)

Clinical efficacy and neuroprotective effects of brimonidine in the management of glaucoma and ocular hypertension
por: Galanopoulos, Anna, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_u6n3pd820d8roll8d8h28u3m3t